Registered entities
INVITAE
Reg. No. 271701898United States
INVITAE CORP
Reg. No. 1501134United States
Invitae Corporation
Reg. No. 27-1701898Belgium
Social engagement
Social engagement: 148.4K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
24 investors on record; lead investors include The Broe Group, Decheng Capital, Deerfield, Orbimed.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 42% |
| Private equity | 1 | 4% |
| Angel & family office | 1 | 4% |
| Accelerator & incubator | 2 | 8% |
| Bank & private debt | 4 | 17% |
| Other / undisclosed | 6 | 25% |
Hiring activity
No recent openings observed
No roles tracked in the last 12 months
30 May 2024 · Cardio, Neurology & Pediatrics, Regional Manager | Kansas City/St Louis · null
30 May 2024 · Cardio, Neurology & Pediatrics, Regional Manager | Nashville, TN · null
7 May 2024 · Regional Sales Manager, Oncology | Kansas · null
7 May 2024 · Regional Sales Manager, Oncology | Dakotas · null
Based on job postings tracked across public sources.
Recent activity
15 Jan 2026
Partnership
Invitae
30 Dec 2025
Leadership hire
21 Oct 2025
Event
integrating both testing modalities can provide a complete view of cancer biology and can influence patient care